Session 01: Rare Diseases
Any illness that affects a very small percentage of the population is considered rare. Rare diseases include uncommon cancers, such as childhood cancers, as well as certain other well-known disorders, such as cystic fibrosisCF, pancreatic fibrosis, mucoviscididosis, fibrosis, and monogenic disorder. Huntington's disease and monogenic disease.
Rare Diseases  &  Health Conference | Rare Diseases Congress | Rare diseases Health  | Rare Diseases and  Health  | Rare Diseases Event | Rare Diseases Conferences

Session 02: Infectious Diseases
Unusually, several words are used to describe infectious diseases. An infectious disease is an ailment brought on by an organism, and illness is the presence of pathology. The ability of an organism to cause illness in a given host is referred to as virulence. The level of the host's resistance to a specific germ is referred to as immunity. Vaccines prevent various infectious diseases, including varicella and morbilli.
Infectious Diseases  &  Rare Diseases Conference |  Infectious Diseases Congress | Rare Diseases Conference | Treatment for Rare Diseases | Rare diseases Health 

Session 03: Rare Cancer Diseases
Rare cancers affect an incredibly small population of people. If a cancer begins in a unique location within the body, it may also be regarded as rare. Or if the cancer is a rare type that requires specialised care and is brought on by ad hoc changes in the body. Experts are unsure of what causes the mutation. Since many people may not exhibit symptoms until later stages, regular blood tests are all that is needed to make the identification.
Rare Diseases  | Cancer Diseases | Rare diseases Health | Rare Cancer Diseases |  Rare Diseases Event | Rare diseases Health | Rare Diseaes Congress  

Session 04: Treatment for Rare Diseases
As eighty percent of rare diseases are caused by a single sequence and gene medical treatment has the potential to repair several genetic abnormalities, it is one of the reasonable strategies to treat rare sequencetic disorders. Restore one sequence defect by introducing a "right" sequence. Additionally, womb-to-tomb improvement may require only a single dosage of outstanding sequence medical therapy.
Rare Diseases  | Treatment for Rare Diseases | Rare Diseases Conference | Rare Diseases and  Health | Rare Diseases Congress | Cancer Treatment  

Session 05: Rare paediatrics Diseases
Rare paediatric illnesses, which can be serious or fatal, affect people from birth to age 18, including the age groups often known as neonates, babies, children, and adolescents. One example of a paediatric rare disease is achondrogenesis Rare Diseases and Health.
Rare diseases  &  Health Conference | Cancer Diseases | Infectious Diseases Congress | Rare diseases Health | Rare Diseases Event 

Session 06: Rare Skin Diseases
The majority of disorders that affect the skin start deep beneath its layers, and these anomalies are crucial in identifying a variety of internal diseases. The inherent region-specific anatomical variability of the skin can significantly alter how a rash appears. This becomes clear after skin is transplanted from one area of the body to another and still displays the morphological traits of the donor area. Hereditary skin illnesses are commonly categorised using gross morphological, histologic, and microscopic results; however, the precise diagnosis is frequently uncertain since skin diseases may not always appear in a recognisable way.
Rare Diseases & Skin Diseases | Rare Skin Diseases | Treatment for Rare Diseases | Infectious Diseases Congress | Rare Diseases Conferences 

Session 07: Rare Diseases in Brain
The main link between brain illnesses and altered brain function or structure is this. this may be primarily due to seizures, state-of-mind, temperament changes, tumours, and infections. Jakob-Creutzfeldt disease (CJD) is an uncommon chronic brain disorder that is characterised by rapidly advancing medical conditions and severe symptoms. Once symptoms start, those who are impacted may experience disorientation, depression, changes in activity, reduced vision, and/or impaired coordination.
Rare diseases & Health Conference | Diseases in Brain | Rare diseases Health | Rare Diseases Conferences | Rare diseases Health  | Rare Diseases in Brain 

Session 08: Rare Genetic Diseases
Rare genetic diseases ar caused by one or a lot of abnormalities within the ordination. it should be caused thanks to mutation in a very single sequence or multiple genes. However, there aren't any proverbial treatments for genetic disorders. several genetic disorders influence stages of development like Down's syndrome, whereas others end in physical symptoms like hereditary condition. thanks to the wide selection of genetic disorders, identification is wide varied and looking on the disorder.
Rare Diseases Conferences | Rare Genetic Diseases | Rare Diseases Congress | Infectious Diseases Congress | Rare Diseases Event 

Session 09: Rare Haematology Diseases
RBC beta monogenic disorder, Diamond-Blackfan anaemia, and other anemia-type red vegetative cell conditions, white vegetative cell dysfunctions associated with various malignancies, and immuno-protoplasm-based abnormalities that affect platelet and lymphocyte disorders are just a few examples of the diverse subcategories of rare medical specialty diseases. Some rare blood illnesses, particularly those that are gene-based, can be distinguished with ease with a simple test, whilst others require substantial research to be properly analysed
Rare Diseases Conference  | Brain Diseases | Rare Haematology Diseases | Rare Diseases and  Health | Infectious Diseases Congress

Session 10: Rare Diseases analysis
Due to the rarity and variety of rare infections, research must be conducted globally to ensure that experts, researchers, and doctors are connected and that clinical trials are conducted internationally so that patients can benefit from the pooling of resources across borders. Patients with rare illnesses still have to endure lengthy wait times in the healthcare system before a firm diagnosis is made.
Rare Diseases Conferences | Rare Diseases analysis | Rare Diseases Congress | Treatment for Rare Diseases | Rare Diseases and  Health 

Session 11: Rare Response Diseases
In later years, national and international associations are established to inform and protect patients affected by these ailments. Rare infections caused by systemic changes represent a field of life science that is very interesting and is constantly expanding. These disorders have a ludicrous social and economic impact because they typically affect young or severely ill children who are at the height of their social activities and relationships.
Rare response Diseases |  Rare Diseases Event | Rare Diseases Congress | Rare Diseases Event | Rare diseases  &  Health Conference

Session 12: Orphan Medicine
Orphan drugs are a group. The medical product designated to treat rare diseases or unusual disorders and intended for the treatment, obstructing, or designation of a rare sickness or condition are called as "orphan medications" due to their niche markets. According to the definition of an orphan disease, it only affects 200,000 people nationwide. The majority of orphan diseases have a genetic basis. One in fifteen people could be affected by an orphan disease worldwide.
Rare diseases & Health Conference | Rare Diseases Conferences | Orphan medicine | Health Conference | Rare Diseases analysis 

Session 13: Rare Endocrine Genetic Diseases
There are numerous rare disorders of the body. According to the National Organization of Eudaimonia, over 175 different rare diseases affect the system, a complex system of organs and glands that uses about 30 different hormones to affect a variety of vital functions, including growth, metabolism, heart function, and fertility. Addison's disease is extremely rare. However, any organ system may likely be affected by rare endocrine illnesses.
Rare Diseases | Rare Endocrine Genetic Diseases | Rare diseases congress | Rare Diseases & Health | Rare Diseases analysis | Rare diseases & Health Conference 

The main driving factors of the rare disease clinical trial industry are the high burden of rare diseases worldwide, which has led to rising demand for research. Furthermore, intermittent launches and a large number of products in the pipeline also propel growth. Government initiatives that encourage product development, such as the Orphan Drug Act, are further expected to assist industry growth.
According to the National Institutes of Health (NIH), there are more than 7,000 rare diseases worldwide. These diseases affect nearly 30 million Americans, or 1 in every 10 people. Eurodis states that 72% of rare diseases are genetic, while others are caused by infections, allergies, and environmental causes. The growing awareness among people regarding rare diseases and growing interest in developing potential treatments for treating rare diseases are expected to support market growth.
Pharmaceutical companies and non-profit organizations are actively providing funding for rare disease clinical research. For instance, in February 2022, the Health Research Board funded USD 1.1 million to support rare disease clinical trials. Similar initiatives in the future are expected to support the market during the forecast period.
Orphan drug sales have been steadily increasing in recent years. For instance, according to Evaluate Pharma, orphan drug sales accounted for USD 138 billion in 2020, and by 2022, they accounted for USD 172 billion. It is estimated that orphan drug sales will reach USD 268 billion by 2026. The rise in the sales of orphan drugs is expected to generate interest among researchers in developing new treatments in the area of rare diseases and thus support the market in the post-pandemic period.
 

Rare Disease Clinical Trials Market Report Highlights
The phase III segment is expected to grow at the fastest CAGR of 10.3% during the forecast period. The segment's growth is supported by the high cost of phase III rare disease clinical trials due to the requirement for a large number of volunteers
The oncology segment held the largest market revenue share of 33.9% in 2022. The growing interest of researchers in the development of new potential treatments for treating rare cancers is supporting the growth of the segment
Based on the sponsor, the nonprofit organization segment is expected to grow at a CAGR of 9.9% over the forecast period owing to the significant funding offered by these organizations to support rare disease clinical research
North America dominated the market and accounted for a revenue share of 49.3% in 2022. The high burden of rare diseases in North America and the presence of a large number of players in clinical trials are some of the key reasons for its high market share 

• Acknowledgment as YRF Awardee
• Promotion on the conference website, Young Researcher Awards, and certificates
• Link on the conference website
• Recognition on Meetings Int. Award Page
• Chances to coordinate with partners around the world
• Research work can be published in the relevant journal without any publication fee

• All presented abstracts will automatically be considered for the Award.
• All the presentations will be evaluated in the conference venue
• All the awards will be selected by the judges of the award category
• The winners of the Young Scientist Award will receive an award certificate.
• The awards will be assessed as far as plan and format, intelligence, argumentation and approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.

• All submissions must be in English.
• The topic must fit into the scientific sessions of the conference
• Each individual participant is allowed to submit a maximum of 2 papers
• An abstract must be submitted online as per the given abstract template
• Abstracts must be written in Times New Roman and the font size will be 12
• The abstract must contain a title, name, affiliation, country, speakers biography, recent photograph, image, and reference